Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 2, 2013, Pages

  Conrad, Kirk P ^a   Baker, Valerie L ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular; In vitro fertilization; Intrauterine growth restriction; Preeclampsia; Relaxin; Renal

Indexed keywords

RELAXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GLOMERULUS FILTRATION; HEART OUTPUT; HYPOTHESIS; INFERTILITY THERAPY; NONHUMAN; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PILOT STUDY; PLASMA OSMOLALITY; PREGNANCY; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS LUTEUM; EMBRYO TRANSFER; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HEMODYNAMICS; HUMANS; INFERTILITY; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RATS; RELAXIN; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 84872378192     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00239.2012     Document Type: Article

References (32)

1. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 6: 978-984, 1999
2. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 6: 978-984, 1999
3. Centers for Disease Control and Prevention. Assisted Reproductive Technology. 2012. http://www.cdc.gov/ART/index.htm.
4. Chapman AB, Zamudio S, Woodmansee W, Merouani A, Osorio F, Johnson A, Moore LG, Dahms T, Coffin C, Abraham WT, Schrier RW. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol Renal Physiol 273: F777-F782, 1997
5. Conrad KP. Unveiling the vasodilatory actions and mechanisms of relaxin. Hypertension 56: 2-9, 2010
6. De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 111: 292-300, 2008
7. Debrah DO, Novak J, Matthews JE, Ramirez RJ, Shroff SG, Conrad KP. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 147: 5126-5131, 2006
8. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 76: 1061-1069, 1990
9. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61-73, 2008
10. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 328: 261, 2004
11. Hermsteiner M, Zoltan DR, Doetsch J, Rascher W, Kuenzel W. Human chorionic gonadotropin dilates uterine and mesenteric resistance arteries in pregnant and nonpregnant rats. Pflügers Arch 439: 186-194, 1999
12. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 103: 551-563, 2004
13. Jeyabalan A, Conrad KP. Renal physiology and pathophysiology in pregnancy. In: Renal and Electrolyte Disorders, edited by Schrier RW. Philadelphia, PA: Lippincott Williams & Wilkins, 2010, p. 462-518
14. Jeyabalan A, Steward D, McGonigal S, Powers RW, Conrad KP. Low relaxin concentrations in the first trimester are assoicated with increased risk of developing preeclampsia. Reproductive Sci 16, Suppl 3: 101A, 2009
15. Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy- induced hypertension in young recipients of donated oocytes. Fertil Steril 87: 776-781, 2007
16. Lindheimer MD, Barron W, Davison J. Osmoregulation of thirst and vasopressin release in pregnancy. Am J Physiol Renal Fluid Electrolyte Physiol 257: F159-F169, 1989
17. Magness RR, Phernetton TM, Zheng J. Systemic and uterine blood flow distribution during prolonged infusion of 17β-estradiol. Am J Physiol Heart Circ Physiol 275: H731-H743, 1998
18. Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 70: 240-245, 1998
19. McGuane JT, Danielson LA, Debrah JE, Rubin JP, Novak J, Conrad KP. Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans. Hypertension 57: 1151-1160, 2011
20. Novak J, Danielson LA, Kerchner LJ, Sherwood OD, Ramirez RJ, Moalli PA, Conrad KP. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 107: 1469-1475, 2001
21. O'Byrne EM, Carriere BT, Sorensen L, Segaloff A, Schwabe C, Steinetz BG. Plasma immunoreactive relaxin levels in pregnant and nonpregnant women. J Clin Endocrinol Metab 47: 1106-1110, 1978
22. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41: 437-445, 2003
23. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47: 203-208, 2006
24. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, Philips S, Allgar V, Walker JJ. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 14: 2268-2273, 1999
25. Sherwood O. Relaxin. In: The Physiology of Reproduction, edited by Knobil ENJ, Greenwald GS, Markert CL, Pfaff DW. New York: Raven, 1994, p. 861-1009
26. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 365: 785-799, 2005
27. Smith MC, Murdoch AP, Danielson LA, Conrad KP, Davison JM. Relaxin has a role in establishing a renal response in pregnancy. Fertil Steril 86: 253-255, 2006
28. Soderstrom-Anttila V, Tiitinen A, Foudila T, Hovatta O. Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies. Hum Reprod 13: 483-490, 1998
29. Stewart DR, Celniker AC, Taylor CA Jr, Cragun JR, Overstreet JW, and Lasley BL. Relaxin in the peri-implantation period. J Clin Endocrinol Metab 70: 1771-1773, 1990
30. Szlachter BN, Quagliarello J, Jewelewicz R, Osathanondh R, Spellacy WN, Weiss G. Relaxin in normal and pathogenic pregnancies. Obstet Gynecol 59: 167-170, 1982
31. Vasapollo B, Valensise H, Novelli GP, Altomare F, Galante A, Arduini D. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction. Ultrasound Obstet Gynecol 24: 23-29, 2004
32. Weiss G, Goldsmith LT, Sachdev R, Von Hagen S, Lederer K. Elevated first-trimester serum relaxin concentrations in pregnant women following ovarian stimulation predict prematurity risk and preterm delivery. Obstet Gynecol 82: 821-828, 1993.